Inspiratory muscle training for people with Parkinson's disease

Not Applicable

Recruiting

• Conditions: Parkinson's disease; Inspiratory muscle weakness; Dyspnoea; Exercise capacity; Quality of life; Difficulty performing daily living activities; Neurological - Parkinson's disease

• Registration Number: ACTRN12622000097741
• Lead Sponsor: niversity of Canberra

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-24
• Last Update Posted: 16 January 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

People with idiopathic Parkinson's disease will asked for consent to participate in the trial. They will also need to have stable Parkison's disease medications, answer ‘yes’ to a question about having ever had trouble with their breathing, and should be able to walk independently with or without usual walking aids.

Exclusion Criteria

Participants should not have uncontrolled chronic or acute cardiovascular (e.g., angina, heart failure) and/or respiratory disease (e.g., asthma, pulmonary oedema) or other neurological conditions (e.g., neuromuscular diseases). Participants will not have undertaken any type of breathing training in the last six months or medical conditions which would preclude or interfere with the assessment or the training program. (i.e., rib fracture, risk of pneumothorax).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inspiratory muscle strength will be assessed as maximal inspiratory pressure (cmH2O) using a portable MicroRPM Respiratory Pressure meter (CareFusion, San Diego, USA).[Measures of inspiratory muscle strength will be recorded at baseline assessment and after 8 weeks by a trained assessor blinded to group allocation.]